For instance, pegylated FGF-21 analogs have demonstrated promising results in treating NAFLD [279], while recombinant FGF-21 (rFGF-21) has demonstrated the ability to ameliorate BBB damage caused by T2DM [286]. Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.